US FDA approves Lilly's Mounjaro to reduce cardiovascular risk - Reuters
US FDA approves Lilly's Mounjaro to reduce cardiovascular risk Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxQbTQ5NEtsQlRFV3RndUxiRTJVN0hibGxMbHBRVFhEamU4RXpHTkJrbzE0Q0lwRy1iVjVpczBTTzRkSkZDNlNvMkgybWRvNWZsbDZ5VnZWNllCN2U2QmtfTWJwRU1WOTAwTk12ajI3bWlkUDZQN1NCcGJzM1BiRkhUSHVFY29xREdLakdZNldEXzNBbzNkYnozcmpicVBXVm54X3VIWk51T0tDZ1dIWHVpZE8xaWdWSllCNUlXU3pMNGRBODU5cnktR2Zn?oc=5" target="_blank">US FDA approves Lilly's Mounjaro to reduce cardiovascular risk</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PMUS FDA flags four deaths in Newron's schizophrenia drug studies - Reuters
US FDA flags four deaths in Newron's schizophrenia drug studies Reuters
October 8, 2026 at 05:47 PMTeva wins FDA approval for monthly schizophrenia injection Weltruza - Reuters
Teva wins FDA approval for monthly schizophrenia injection Weltruza Reuters
October 9, 2026 at 11:47 AMWHO endorses lifestyle changes over GLP-1 drugs in child obesity fight - Reuters
WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight Reuters
October 7, 2026 at 07:39 AMUS FDA approves Asahi Kasei's drug for persistent herpes infections - Reuters
US FDA approves Asahi Kasei's drug for persistent herpes infections Reuters
October 9, 2026 at 06:01 PMReliance sues India's food regulator over 'energy drink' label ban - Reuters
Reliance sues India's food regulator over 'energy drink' label ban Reuters
October 6, 2026 at 04:18 AM